Skip to main content

previous disabled Page of 7
and
  1. No Access

    Chapter and Conference Paper

    Economic Evaluation of Orthopedic and Surgical Interventions in Hemophiliacs - Not Only Direct Medical Costs Matter

    D. Mihailov, M. Serban, R. Badeti, P. Tepeneu in 36th Hemophilia Symposium Hamburg 2005 (2007)

  2. No Access

    Chapter and Conference Paper

    Blood Borne Infections in Hemophiliacs in a Develo** Country. A Single Center Experience

    NBP are still a factor of concern in patients with hemophilia despite the more efficient screening methods introduced in the last decade in our country. From this perspective, clotting factor concentrates are ...

    M. Serban, M. Pop, St. Jenariu, L. Pop, C. **ca in 36th Hemophilia Symposium Hamburg 2005 (2007)

  3. No Access

    Chapter and Conference Paper

    HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 2004/2005 Survey)

    Comparing actual data to those of the previous surveys we again got very consistent findings indicating fairly good data quality. In addition our data are comparable to that of international large-scale preval...

    H. Krebs, W. Schramm in 36th Hemophilia Symposium Hamburg 2005 (2007)

  4. No Access

    Chapter and Conference Paper

    National Hemophilia Registry - Source of Information about the Quality of Hemophilia Medical Care in a Develo** Country

    D. Lighezan, F. Vladareanu, V. Uscatescu in 36th Hemophilia Symposium Hamburg 2005 (2007)

  5. No Access

    Chapter and Conference Paper

    HCV-Infection in HIV-Infected and Non-Infected People with Hemophilia — A Retrospective Study: Psychosocial Aspects

    Our results show evidently that the psychosocial factors are of high importance besides the medical suppositions. We have to concede that part of our psychosocial data was gained retrospectively, so these resu...

    M. M. Schneider, H. Krebs, W. Schramm in 35th Hemophilia Symposium (2006)

  6. No Access

    Chapter and Conference Paper

    HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 2003/2004 Survey)

    W. Schramm, H. Krebs in 35th Hemophilia Symposium (2006)

  7. No Access

    Chapter and Conference Paper

    Lack of Factor VIII Expression Represents a Novel Mechanism Leading to Hemophilia A

    O. El-Maarri, H. Singer, H.-H. Brackmann, J. Schröder, J. Graw in 35th Hemophilia Symposium (2006)

  8. No Access

    Chapter and Conference Paper

    Socio-Economic Aspects of Hemophilia Treatment in Romania

    D. Mihailov, M. Şerban, B. Lippert, W. Schramm, S. Arghirescu in 35th Hemophilia Symposium (2006)

  9. No Access

    Chapter and Conference Paper

    HCV-Infection in HIV-Infected and Non-Infected People with Hemophilia — A Retrospective Study: Medical Aspects

    Despite mortality from HIV in patients with hemophilia is kee** on decreasing, HIV still remains an important factor as an HIV/HCV co-infection seems to increase risk of progression of liver disease to cirrh...

    H. Krebs, M. M. Schneider, W. Schramm in 35th Hemophilia Symposium (2006)

  10. No Access

    Chapter and Conference Paper

    Successful Major Surgery with Minimal Dosage of rFVIIa in a Hemophilia A Patient with High Level of Alloantibodies to Factor VIII

    The experience of a favorable outcome of an elective major orthopedic surgical procedure performed in a severe case of hemophilia A with high titer inhibitors is presented. Specific for the presented case is t...

    M. Şerban, P. Tepeneu, S. Arghirescu, R. Badeţi, C. **ca in 35th Hemophilia Symposium (2006)

  11. No Access

    Chapter and Conference Paper

    Quality of Life Autoevaluation of Hemophilia Patients in Romania

    The problem of quality of life in chronic patients remains a concern for the health care system, its improvement being an aim as important as the discovery of new therapeutic methods. Furthermore, quality of l...

    D. Mihailov, M. Jernea, V. Serban, S. Arghirescu, M. Serban in 33rd Hemophilia Symposium (2004)

  12. No Access

    Chapter and Conference Paper

    HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 2001/2002 Survey)

    The annually survey “HIV Infection and Causes of Death in Patients with Hemophilia in Germany” goes along with a fine tradition. Already in the late 1970s Professor Landbeck began to survey annually hemophilia...

    W. Schramm, H. Krebs in 33rd Hemophilia Symposium (2004)

  13. No Access

    Chapter and Conference Paper

    Modified Immunsuppression in a Case of Acquired Hemophilia — Case Report

    A 62-year-old female patient with suspicion on ovarial carcinoma was introduced. An unclear bleeding disorder persisted for about six months. In addition a mama carcinoma (pT1b, pN0, pM0) without indications o...

    H. Krebs, C. Domsch, W. Schramm, M. Spannagl in 33rd Hemophilia Symposium (2004)

  14. No Access

    Chapter and Conference Paper

    Recombinant Human Interferon α-2b Therapy, for Refractory Immune Thrombocytopenic Purpura in Children

    The study was designed to evaluate the effect of a-IFN, in patients with chronic immune thrombocytopenic purpura (ITP) who did not respond to conventional therapy; there were included 10 patients; 5 of them as...

    M. Serban, V. Borla, C. Petrescu, S. Arghirescu, I. Cuca in 33rd Hemophilia Symposium (2004)

  15. No Access

    Chapter and Conference Paper

    Analysis of Factor VIII RNA from Hemophilia A Patients with no Detectable Mutation in the Coding Regions

    Here on we report on the detailed RNA analysis of the factor VIII cDNA from patients that have either putative splicing site mutations or patients with no previously detected DNA mutations by mutation screenin...

    O. El-Maarri, U. Herbiniaux, M. Watzka, J. Graw, C. Uen in 33rd Hemophilia Symposium (2004)

  16. No Access

    Chapter and Conference Paper

    Functional Assessment of fibrinolytic Resistance in whole Blood

    Venous thromboembolism represents a significant cause of Morbidity worldwide [1]. Korninger et al. [2] suggested that an impaired fibrinolytic response to venous occlusion May predispose to recurrent thrombosi...

    A. Werni, A. Calatzis, W. Schramm, M. Spannagl in 32nd Hemophilia Symposium (2003)

  17. No Access

    Chapter and Conference Paper

    Socio-economic Evaluation of Hemophilia Assistance

    The inadequate treatment, as well as the absence of prophylactic therapy of hemophiliacs in Romania lead to unfavorable long and short-term consequences (lifethreatening and non-life threatening bleedings, chr...

    D. Mihailov, K. Schramm, W. Schramm, M. Şerban, D. Lighezan in 32nd Hemophilia Symposium (2003)

  18. No Access

    Chapter and Conference Paper

    HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 2000/2001 Survey)

    Already in the late 1970s Professor Landbeck began to survey annually hemophiliacs living at that time in West Germany for causes of death and the prevalence of diseases. The early questionnaires used in the s...

    W. Schramm, H. Krebs in 32nd Hemophilia Symposium (2003)

  19. No Access

    Chapter and Conference Paper

    Aspects regarding Locomotor Rehabilitation of Hemophiliacs

    Progressive joint disease due to recurrent hemarthrosis and Muscular bleedings or atrophy are the source of a significant Morbidity and disability for hemophiliacs. They are common Manifestations particularly ...

    M. Şerban, V. Şerban, H. Schuszler, D. Lighezan, D. Mihailov in 32nd Hemophilia Symposium (2003)

  20. No Access

    Chapter and Conference Paper

    11 novel Mutations in the Factor VIII encoding Gene lead to severe or moderate Hemophilia A

    In Germany, approximately 5800 patients are suffering from hemophilia A. In a systematic large-scale analysis we will identify the genotype of all severe cases (approximately 3000 patients). A first screening ...

    C. Uen, N. Klopp, J. Oldenburg, H.-H. Brackmann, W. Schramm in 32nd Hemophilia Symposium (2003)

previous disabled Page of 7